title: The role of systemic treatment before, during, and after definitive treatment.
abstract: In locoregionally advanced head and neck squamous cell carcinomas, outcomes using single-modality therapy are usually poor. Although chemotherapy alone is not considered a curative therapy, the addition of chemotherapy to other modalities can lead to improved outcomes. Discussed here is the use of chemotherapy for oropharyngeal and/or oral cavity squamous cell carcinomas in 3 settings: in combination with radiation as definitive therapy, as induction treatment before definitive therapy, and in combination with radiation therapy as adjuvant treatment following surgical resection. The role of the targeted agent cetuximab in combination with radiation therapy for locally advanced disease is also discussed.
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Gold
authors.forename: Michele
authors.initials: M
authors.lastname: Neskey
authors.forename: William N
authors.initials: WN
authors.lastname: William
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D060828:Induction Chemotherapy
chemical_list: D000970:Antineoplastic Agents
keywords: Chemotherapy; Oropharyngeal squamous cell carcinomas; Squamous cell carcinoma; Systemic treatment; Targeted therapy
references.citation: Ann Oncol. 2010 Nov;21(11):2272-2277
references.pmid: 20427350
references.citation: Cancer. 1979 Jul;44(1):19-25
references.pmid: 88255
references.citation: Lancet Oncol. 2010 Jan;11(1):21-8
references.pmid: 19897418
references.citation: N Engl J Med. 2003 Nov 27;349(22):2091-8
references.pmid: 14645636
references.citation: N Engl J Med. 2004 May 6;350(19):1937-44
references.pmid: 15128893
references.citation: J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
references.pmid: 18270337
references.citation: J Clin Oncol. 2003 Jan 1;21(1):92-8
references.pmid: 12506176
references.citation: Ann Oncol. 2011 May;22(5):1071-1077
references.pmid: 21317223
references.citation: J Natl Cancer Inst. 1996 Jul 3;88(13):890-9
references.pmid: 8656441
references.citation: J Clin Oncol. 2014 Sep 20;32(27):2940-50
references.pmid: 25154822
references.citation: Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1421-3
references.pmid: 93595
references.citation: J Natl Cancer Inst. 2004 Nov 17;96(22):1714-7
references.pmid: 15547184
references.citation: Head Neck. 2005 Oct;27(10):843-50
references.pmid: 16161069
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2171-7
references.pmid: 17538161
references.citation: N Engl J Med. 2007 Oct 25;357(17):1695-704
references.pmid: 17960012
references.citation: J Clin Oncol. 2006 Feb 1;24(4):593-8
references.pmid: 16380415
references.citation: J Natl Cancer Inst. 1999 Dec 15;91(24):2081-6
references.pmid: 10601378
references.citation: N Engl J Med. 2007 Oct 25;357(17):1705-15
references.pmid: 17960013
references.citation: BMC Cancer. 2006 Jan 31;6:28
references.pmid: 16448551
references.citation: N Engl J Med. 2008 Mar 13;358(11):1160-74
references.pmid: 18337605
references.citation: J Clin Oncol. 1996 May;14(5):1672-8
references.pmid: 8622087
references.citation: N Engl J Med. 2008 Sep 11;359(11):1116-27
references.pmid: 18784101
references.citation: Lancet Oncol. 2011 Feb;12(2):153-9
references.pmid: 21233014
references.citation: Br J Cancer. 2000 Dec;83(12):1594-8
references.pmid: 11189100
references.citation: Cancer. 1979 Mar;43(3):1025-31
references.pmid: 85477
references.citation: N Engl J Med. 1991 Jun 13;324(24):1685-90
references.pmid: 2034244
references.citation: J Clin Oncol. 2010 Jan 1;28(1):8-14
references.pmid: 19917840
references.citation: Cancer. 1985 Mar 1;55(5):1123-8
references.pmid: 4038469
references.citation: Radiother Oncol. 1997 Apr;43(1):29-37
references.pmid: 9165134
references.citation: J Clin Oncol. 2004 Jan 1;22(1):69-76
references.pmid: 14657228
references.citation: J Natl Cancer Inst. 1994 Feb 16;86(4):265-72
references.pmid: 8158680
references.citation: N Engl J Med. 2004 May 6;350(19):1945-52
references.pmid: 15128894
references.citation: Lancet. 2000 Mar 18;355(9208):949-55
references.pmid: 10768432
references.citation: N Engl J Med. 2006 Feb 9;354(6):567-78
references.pmid: 16467544
references.citation: Radiother Oncol. 2009 Jul;92(1):4-14
references.pmid: 19446902
references.citation: Radiology. 1970 Apr;95(1):185-8
references.pmid: 4190460
references.citation: J Clin Oncol. 2009 Apr 20;27(12):1976-82
references.pmid: 19289628
references.citation: Head Neck. 2010 Feb;32(2):221-8
references.pmid: 19557750